News and Trends 10 Jul 2017
Swiss Biotech Starts Phase II Trial to Treat Motor Symptoms of Parkinson’s
Prexton Therapeutics has launched a Phase II trial to test whether its drug foliglurax can treat the motor complications of standard…
Parkinson’s
- Latest Posts
News and Trends 6 Jul 2017
Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II
Prothena and Roche are advancing their Parkinson's antibody to Phase II, triggering a new milestone payment from what is proving…
News and Trends 12 May 2017
UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval
UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its partner, Zambon, which has the…
Interview 20 Apr 2017
Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years
Philip talked to Stefan Weber, CEO of Newron Pharmaceuticals, in our first meetup in Munich last week. His company has…
ADVERTISEMENT
News and Trends 11 Apr 2017
New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK
Mission Therapeutics has received a grant to support the development of a novel approach to treating Parkinson's that is attracting…
News and Trends 13 Feb 2017
Biotech from the Bermuda Islands Brings Good News for Dementia Patients
Axovant Sciences has announced positive preliminary results from a Phase II trial directed at reducing hallucinations in patients with dementia.…
News and Trends 7 Feb 2017
Swiss Parkinson’s Biotech raises Massive €29M in Series B from Top European VCs
Top European VCs have invested €29M in Prexton Therapeutics to support two Phase II trials of its lead candidate foliglurax…
News and Trends 19 Dec 2016
Evotec closes the year partnering with Celgene to treat Alzheimer’s
Evotec is closing a fantastic financial year with another top-level partnership; Celgene has decided to trust in its iPSC platform…
News and Trends 21 Oct 2016
New Partnership comes to the Rescue in Neurological Diseases
Developing effective treatments for neurological diseases is a big challenge in medicine. But here come UCB and Evotec with a new…
News and Trends 18 Oct 2016
This New Biotech wants to Regrow Neurons to cure Parkinson’s
Mavalon Therapeutics will develop a drug candidate for Parkinson's that can stop the disease progression by activating the growth of…
ADVERTISEMENT
News and Trends 17 Oct 2016
Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize
Just after the Nobel Prize was awarded to the study of autophagy, PhoreMost announces a collaboration to target the process…
News and Trends 11 Oct 2016
World Mental Health Day: How is Biotech Helping the Cause?
Biotech is one of the main forces driving the development of effective therapies to treat neurological and mental disorders. For World Mental…
News and Trends 28 Sep 2016
ITW: Prexton Therapeutics CEO explains Development of new Parkinson’s Drug
For our first interview at the SACHS Conference in Basel yesterday, I met with François Conquet, founder and CEO of Prexton Therapeutics.…
News and Trends 29 Jun 2016
Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s
AFFiRiS has received €10M from previous investors and one additional backer, adding up to €130M in total funding (half from grants…
News and Trends 27 May 2016
Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease
The Scandinavian charm is wonderful but this week we are (finally) heading back to Central Europe. Do I really need…
News and Trends 11 Apr 2016
It’s World Parkinson’s Disease Day! #EndParkinsons
Today (April 11th) is the birthday of the memorable Dr James Parkinson, who discovered this major neurodegenerative disease. So what…
ADVERTISEMENT
News and Trends 8 Jan 2016
Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists
Founded in just 2013 by German Proteros and the US Atlas Ventures, Rodin Therapeutics is working epigenetics into discovery of…
News and Trends 24 Nov 2015
2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?
Since both Alzheimer's Disease and Parkinson's combined affect up to 50 million people worldwide, it is no wonder this new…
News and Trends 20 Nov 2015
Get to Know the Top 50 Women in the UK’s Biotech Scene
The Movers & Shakers Report 2015 lists 50 of the Top female Bio-Entrepreneurs... here's a select few I found particularly…
News and Trends 16 Nov 2015
Swissmedic Approves Zambon and Newron Therapy against Parkinson’s
Italian Pharma Newron and its partner Zambon (from Milan) have been granted a license by Swissmedic (the regulatory agency in Switzerland)…
